FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046353721> ?p ?o ?g. }

• W2046353721 endingPage "665" @default.
• W2046353721 startingPage "655" @default.
• W2046353721 abstract "Therapeutic targeting of melanoma antigens frequently focuses on the melanocyte differentiation or cancer-testis families. Antigen-loss variants can often result, as these antigens are not critical for tumor cell survival. Exploration of functionally relevant targets has been limited. The melanoma inhibitor of apoptosis protein (ML-IAP; livin) is overexpressed in melanoma, contributing to disease progression and treatment resistance. Improved understanding of the significance of ML-IAP immune responses in patients has possible therapeutic applications. We found ML-IAP frequently expressed in melanoma metastases by immunohistochemistry. To assess spontaneous immunity to ML-IAP, an overlapping peptide library representing full-length protein was utilized to screen cellular responses in stage I-IV patients and healthy controls by ELISPOT. A broad array of CD4(+) and CD8(+) cellular responses against ML-IAP was observed with novel class I and class II epitopes identified. Specific HLA-A*0201 epitopes were analyzed further for frequency of reactivity. The generation of specific CD4(+) and cytotoxic T cells revealed potent functional capability including cytokine responsiveness to melanoma cell lines and tumor cell killing. In addition, recombinant ML-IAP protein used in an ELISA demonstrated high titer antibody responses in a subset of patients. Several melanoma patients who received CTLA-4 blockade with ipilimumab developed augmented humoral immune responses to ML-IAP as a function of treatment which was associated with beneficial clinical outcomes. High frequency immune responses in melanoma patients, associations with favorable treatment outcomes, and its essential role in melanoma pathogenesis support the development of ML-IAP as a disease marker and therapeutic target." @default.
• W2046353721 created "2016-06-24" @default.
• W2046353721 creator A5018856906 @default.
• W2046353721 creator A5031817044 @default.
• W2046353721 creator A5034124370 @default.
• W2046353721 creator A5036852334 @default.
• W2046353721 creator A5060655774 @default.
• W2046353721 creator A5071788399 @default.
• W2046353721 creator A5084967339 @default.
• W2046353721 date "2011-10-28" @default.
• W2046353721 modified "2023-10-02" @default.
• W2046353721 title "Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma" @default.
• W2046353721 cites W147472336 @default.
• W2046353721 cites W1733656319 @default.
• W2046353721 cites W1963907763 @default.
• W2046353721 cites W1964122379 @default.
• W2046353721 cites W1974292922 @default.
• W2046353721 cites W1976457595 @default.
• W2046353721 cites W1977273255 @default.
• W2046353721 cites W1982013078 @default.
• W2046353721 cites W1983621184 @default.
• W2046353721 cites W1988936558 @default.
• W2046353721 cites W1992606149 @default.
• W2046353721 cites W1992856023 @default.
• W2046353721 cites W2005253163 @default.
• W2046353721 cites W2006987944 @default.
• W2046353721 cites W2007612737 @default.
• W2046353721 cites W2012895611 @default.
• W2046353721 cites W2015009944 @default.
• W2046353721 cites W2025522492 @default.
• W2046353721 cites W2027075102 @default.
• W2046353721 cites W2032468170 @default.
• W2046353721 cites W2045241662 @default.
• W2046353721 cites W2045742924 @default.
• W2046353721 cites W2049891273 @default.
• W2046353721 cites W2060677148 @default.
• W2046353721 cites W2073573249 @default.
• W2046353721 cites W2081027784 @default.
• W2046353721 cites W2082792820 @default.
• W2046353721 cites W2087090271 @default.
• W2046353721 cites W2096385955 @default.
• W2046353721 cites W2097995306 @default.
• W2046353721 cites W2113943474 @default.
• W2046353721 cites W2114064307 @default.
• W2046353721 cites W2122507780 @default.
• W2046353721 cites W2128108747 @default.
• W2046353721 cites W2142614342 @default.
• W2046353721 cites W2146226600 @default.
• W2046353721 cites W2146448606 @default.
• W2046353721 cites W2150215673 @default.
• W2046353721 cites W2154740729 @default.
• W2046353721 cites W2162646864 @default.
• W2046353721 cites W2164584613 @default.
• W2046353721 cites W2165142928 @default.
• W2046353721 doi "https://doi.org/10.1007/s00262-011-1124-1" @default.
• W2046353721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3337996" @default.
• W2046353721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22033581" @default.
• W2046353721 hasPublicationYear "2011" @default.
• W2046353721 type Work @default.
• W2046353721 sameAs 2046353721 @default.
• W2046353721 citedByCount "22" @default.
• W2046353721 countsByYear W20463537212012 @default.
• W2046353721 countsByYear W20463537212013 @default.
• W2046353721 countsByYear W20463537212014 @default.
• W2046353721 countsByYear W20463537212015 @default.
• W2046353721 countsByYear W20463537212016 @default.
• W2046353721 countsByYear W20463537212017 @default.
• W2046353721 countsByYear W20463537212018 @default.
• W2046353721 countsByYear W20463537212019 @default.
• W2046353721 countsByYear W20463537212021 @default.
• W2046353721 countsByYear W20463537212022 @default.
• W2046353721 crossrefType "journal-article" @default.
• W2046353721 hasAuthorship W2046353721A5018856906 @default.
• W2046353721 hasAuthorship W2046353721A5031817044 @default.
• W2046353721 hasAuthorship W2046353721A5034124370 @default.
• W2046353721 hasAuthorship W2046353721A5036852334 @default.
• W2046353721 hasAuthorship W2046353721A5060655774 @default.
• W2046353721 hasAuthorship W2046353721A5071788399 @default.
• W2046353721 hasAuthorship W2046353721A5084967339 @default.
• W2046353721 hasBestOaLocation W20463537211 @default.
• W2046353721 hasConcept C147483822 @default.
• W2046353721 hasConcept C167672396 @default.
• W2046353721 hasConcept C195616568 @default.
• W2046353721 hasConcept C203014093 @default.
• W2046353721 hasConcept C2777658100 @default.
• W2046353721 hasConcept C2777701055 @default.
• W2046353721 hasConcept C2779053233 @default.
• W2046353721 hasConcept C2781433595 @default.
• W2046353721 hasConcept C502942594 @default.
• W2046353721 hasConcept C71924100 @default.
• W2046353721 hasConcept C86803240 @default.
• W2046353721 hasConcept C8891405 @default.
• W2046353721 hasConceptScore W2046353721C147483822 @default.
• W2046353721 hasConceptScore W2046353721C167672396 @default.
• W2046353721 hasConceptScore W2046353721C195616568 @default.
• W2046353721 hasConceptScore W2046353721C203014093 @default.
• W2046353721 hasConceptScore W2046353721C2777658100 @default.
• W2046353721 hasConceptScore W2046353721C2777701055 @default.

• next